Literature DB >> 7814485

Identification of an immunodominant 32-kilodalton membrane protein of Leishmania donovani infantum promastigotes suitable for specific diagnosis of Mediterranean visceral leishmaniasis.

F Tebourski1, A el Gaied, H Louzir, R Ben Ismail, R Kammoun, K Dellagi.   

Abstract

Sera from 35 patients suffering from Mediterranean visceral leishmaniasis (caused by Leishmania donovani infantum) and 59 patients with various forms of cutaneous leishmaniasis prevalent in the sub-Mediterranean countries (caused by Leishmania major, L. donovani infantum, or Leishmania tropica) were tested by immunoblotting and enzyme-linked immunosorbent assay (ELISA) with both membrane and soluble antigens prepared from L. donovani infantum parasites. Control sera were from healthy children (n = 41), adults with nonleishmanial diseases (n = 40), and patients with Chagas' disease (n = 12). A P32 antigen present in the membrane preparation from L. donovani infantum parasites was recognized by 95% of serum specimens from patients with Mediterranean visceral leishmaniasis but not by serum specimens from patients with cutaneous leishmaniasis or sera from control individuals. An ELISA with electroeluted P32 antigen was found to have a specificity and sensitivity of 94% in the serodiagnosis of Mediterranean visceral leishmaniasis. Healthy children with asymptomatic Leishmania infection were seronegative for the P32 antigen by ELISA. These results suggest that antibodies to P32 antigen develop only in patients with visceral leishmaniasis and that the P32 ELISA may be useful in areas where the disease is endemic for discriminating between patients with this disease and those with other clinical conditions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7814485      PMCID: PMC264086          DOI: 10.1128/jcm.32.10.2474-2480.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Detection of potentially diagnostic leishmanial antigens by western blot analysis of sera from patients with kala-azar or multilesional cutaneous leishmaniasis.

Authors:  C Bogdan; N Stosiek; H Fuchs; M Röllinghoff; W Solbach
Journal:  J Infect Dis       Date:  1990-12       Impact factor: 5.226

2.  Purification of two Leishmania donovani membrane proteins recognized by sera from patients with visceral leishmaniasis.

Authors:  C L Jaffe; M Zalis
Journal:  Mol Biochem Parasitol       Date:  1988-01-01       Impact factor: 1.759

3.  Profile of human T cell response to leishmanial antigens. Analysis by immunoblotting.

Authors:  P C Melby; F A Neva; D L Sacks
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

4.  Evaluation of antibody responses in American visceral leishmaniasis by ELISA and immunoblot.

Authors:  T G Evans; E C Krug; M E Wilson; A W Vasconcelos; J E de Alencar; R D Pearson
Journal:  Mem Inst Oswaldo Cruz       Date:  1989 Apr-Jun       Impact factor: 2.743

5.  IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas' disease and leishmaniasis.

Authors:  T M Chiller; M A Samudio; G Zoulek
Journal:  Am J Trop Med Hyg       Date:  1990-12       Impact factor: 2.345

6.  Diagnostic performance indices for immunofluorescent tests and enzyme immunoassays of leishmaniasis sera from northern and north-eastern Brazil.

Authors:  M C Guimarães; B J Celeste; E L Franco
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

Review 7.  Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection.

Authors:  A Sher; R T Gazzinelli; I P Oswald; M Clerici; M Kullberg; E J Pearce; J A Berzofsky; T R Mosmann; S L James; H C Morse
Journal:  Immunol Rev       Date:  1992-06       Impact factor: 12.988

8.  Identification of the promastigote surface protease in seven species of Leishmania.

Authors:  J Bouvier; R Etges; C Bordier
Journal:  Mol Biochem Parasitol       Date:  1987-05       Impact factor: 1.759

9.  Immunoblot analysis of the humoral immune response to Leishmania donovani infantum polypeptides in human visceral leishmaniasis.

Authors:  L Rolland-Burger; X Rolland; C W Grieve; L Monjour
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

10.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.

Authors:  F P Heinzel; M D Sadick; S S Mutha; R M Locksley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

View more
  8 in total

1.  Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis.

Authors:  E Ghedin; W W Zhang; H Charest; S Sundar; R T Kenney; G Matlashewski
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

2.  Performance of immunoblotting in diagnosis of visceral Leishmaniasis in human immunodeficiency virus-Leishmania sp.-coinfected patients.

Authors:  G Santos-Gomes; S Gomes-Pereira; L Campino; M D Araújo; P Abranches
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Proteomic approach for characterization of immunodominant membrane-associated 30- to 36-kiloDalton fraction antigens of Leishmania infantum promastigotes, reacting with sera from Mediterranean visceral leishmaniasis patients.

Authors:  Sayda Kamoun-Essghaier; Ikram Guizani; Jean Marc Strub; Alain Van Dorsselaer; Kamel Mabrouk; Lazhar Ouelhazi; Koussay Dellagi
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

4.  Evaluation of cleaving agents other than trypsin in direct agglutination test for further improving diagnosis of visceral leishmaniasis.

Authors:  A el Harith; S Chowdhury; A al-Masum; S Semião-Santos; E Karim; S el-Safi; I Haque
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

5.  Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.

Authors:  Rajesh Ravindran; Khairul Anam; Bibhas C Bairagi; Bibhuti Saha; Netai Pramanik; Subhasis K Guha; Rama P Goswami; Dwijadas Banerjee; Nahid Ali
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

Review 6.  Understanding Leishmania parasites through proteomics and implications for the clinic.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Rev Proteomics       Date:  2018-05-02       Impact factor: 3.940

7.  Systematic review on antigens for serodiagnosis of visceral leishmaniasis, with a focus on East Africa.

Authors:  Vera Kühne; Zahra Rezaei; Paul Pitzinger; Philippe Büscher
Journal:  PLoS Negl Trop Dis       Date:  2019-08-15

Review 8.  Place of Serology in the Diagnosis of Zoonotic Leishmaniases With a Focus on Visceral Leishmaniasis Due to Leishmania infantum.

Authors:  Maude F Lévêque; Laurence Lachaud; Loïc Simon; Emilie Battery; Pierre Marty; Christelle Pomares
Journal:  Front Cell Infect Microbiol       Date:  2020-02-25       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.